ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,247.79
-0.41%
Dow Jones
39,112.16
-0.76%
Gold vs US Dollar
2,320.285
-0.46%
Brent Oil
84.185
-1.27%
Bitcoin
61,900.19
2.72%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Virax Biolabs Group Ltd (VRAX) Share Price

VRAX Virax Biolabs Group Ltd

1.32
0.03 (2.33%)
After Hours
Last Updated: 22:40:36
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Virax Biolabs Group Ltd NASDAQ:VRAX NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.03 2.33 1.32 1.32 1.37 1.3859 1.2901 1.3 44,638 21:40:36   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 In Vitro,in Vivo Diagnostics 9k -5.46M -3.5093 -0.38 2.1M
 Type  Size  Price  Time  Units 
 9 20 1.33 22:03:19 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore VRAX News
11/06/202421:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
25/04/202413:00PRNUSVirax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024
16/04/202412:30PRNUSVirax Biolabs to Participate at ESCMID Global 2024
15/03/202420:30PRNUSVirax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency
22/01/202422:28EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
22/01/202422:27EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
12/01/202412:43EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Period
Draw mode
Data Downloads for VRAX

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Virax Biolabs Group Ltd Articles